Print Page
Close Window
2019 Press Releases
FILTER:
SHOW ALL
2019
2018
2017
2016
2015
Keyword Search
February 20, 2019
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
READ MORE
February 19, 2019
Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
READ MORE
January 4, 2019
Ovid Therapeutics Outlines 2019 Clinical and Business Priorities
READ MORE
